- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 14/725 - Récepteurs de lymphocytes-T
Détention brevets de la classe C07K 14/725
Brevets de cette classe: 7505
Historique des publications depuis 10 ans
|
303
|
399
|
508
|
714
|
825
|
1008
|
1173
|
939
|
791
|
64
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1170 |
569 |
| The Trustees of the University of Pennsylvania | 4260 |
230 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
215 |
| Memorial Sloan-Kettering Cancer Center | 1890 |
136 |
| The Regents of the University of California | 19517 |
129 |
| Autolus Limited | 249 |
126 |
| Novartis AG | 11254 |
106 |
| Board of Regents, The University of Texas System | 5619 |
102 |
| Juno Therapeutics, Inc. | 375 |
101 |
| Cellectis | 407 |
88 |
| CRISPR Therapeutics AG | 368 |
86 |
| Regeneron Pharmaceuticals, Inc. | 3986 |
83 |
| City of Hope | 960 |
80 |
| Immunocore Limited | 204 |
74 |
| Adaptimmune Limited | 177 |
71 |
| Lentigen Technology, Inc. | 95 |
71 |
| Kite Pharma, Inc. | 392 |
69 |
| Fred Hutchinson Cancer Center | 416 |
65 |
| The Board of Trustees of the Leland Stanford Junior University | 6246 |
57 |
| The General Hospital Corporation | 4650 |
50 |
| Autres propriétaires | 4997 |